Lv31
364 积分 2022-09-16 加入
Reconsidering OCD pharmacotherapy: The case for levomilnacipran as a safer alternative to clomipramine
8小时前
求助中
Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies
8小时前
已完结
Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis
6天前
已完结
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
7天前
已完结
Pretomanid for the treatment of drug resistant pulmonary tuberculosis: a comprehensive review
9天前
已完结
Pretomanid: The latest USFDA-approved anti-tuberculosis drug
9天前
已完结
Pretomanid: First Approval
9天前
已完结
Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice?
10天前
已完结
Pretomanid: The latest USFDA-approved anti-tuberculosis drug
10天前
已完结
Lotilaner for Demodex Blepharitis: The Journey from Veterinary Use to Human Medicine
12天前
已完结
皖公网安备34019202002308
